From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapy.
about
Purinergic signalling and cancerImmunological alterations mediated by adenosine during host-microbial interactionsMuch ado about adenosine: adenosine synthesis and function in regulatory T cell biology.CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppressionBotulinum neurotoxin type A inhibits synaptic vesicle 2 expression in breast cancer cell linesAdenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells.A(2B) adenosine receptors in immunity and inflammation.The paradoxical immuno-response of adenosine triphosphate effects.Regulation of leukocyte function by adenosine receptors.Targeting the tumor microenvironment by immunotherapy: part 2.Design and application of locally delivered agonists of the adenosine A(2A) receptor.Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy.Potential Therapeutic Applications of Adenosine A2A Receptor Ligands and Opportunities for A2A Receptor Imaging.Design and evaluation of xanthine based adenosine receptor antagonists: potential hypoxia targeted immunotherapies.Fluorinated Adenosine A2A Receptor Antagonists Inspired by Preladenant as Potential Cancer Immunotherapeutics.
P2860
Q24618782-AF1727F3-27D8-4D73-97C1-712F56607B9BQ30426800-B6D6E5BE-30E3-48DB-AE48-D41E2790794CQ30433245-F53EFD48-73DC-44CD-8463-A9ED9455027BQ33533705-B285F76E-8E8B-49BB-A543-9D1F52B6D128Q36014422-92111E3C-DD9F-4862-A15F-A3674FA4E638Q36821572-8189D4B8-BF8F-4757-98D0-20BFF4B03780Q37249932-23215CC7-3511-4A82-94E7-01ADCA9E320DQ37373680-6A4EB718-F440-4597-B912-2CEA02EA404BQ37623823-3D891014-E113-4EFE-87F3-DDA9684B0283Q37876538-9E06DCEF-0330-4AB0-898A-1830EE52A9DDQ37952796-9E7023DE-8D83-4F01-AA5F-879A3EB25E90Q37960072-E971302B-72F3-4E81-9384-028EA9746000Q38406861-D5A4B668-AC7E-48C3-97C2-DBD259131FE2Q38765118-A28C9366-F339-4F90-927E-16E51CC28AC1Q39078481-CA4721F0-F23A-40BD-BB87-6418B6B6FD06Q45305819-3BD071DB-8CEF-466A-8663-B10005FC2B72
P2860
From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapy.
@en
type
label
From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapy.
@en
prefLabel
From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapy.
@en
P2093
P2860
P1476
From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapy.
@en
P2093
Dmitriy Lukashev
Michail Sitkovsky
P2860
P2888
P304
P356
10.1007/S11302-006-9044-9
P577
2007-01-24T00:00:00Z